Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Clinical trial NCT05989425 · UNKNOWN

Trial details

NCT number: NCT05989425
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Differentiated Thyroid Cancer

Start date: 2023-08-04
Primary completion: 2026-08-04
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.